2m 2m 2m 2m 2m 2m 2m
VAXCYTE (PCVX)
NASDAQ
$56.48+$0.43 (+0.76%)
Price as of Oct 02, 2026 5:18 PM EDT- $8.3BMarket Cap
- 39.67%1-Year Change
- BiotechnologyIndustry
VAXCYTE (PCVX)
$56.48+$0.43 (+0.76%)
PCVX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $56.05 | ||
Change | -$0.85 (-1.49%) | ||
Open | $56.73 | ||
High | $57.17 | ||
Low | $55.99 | ||
Previous Close | $56.90 | ||
Volume | 1,166,262 | ||
30-Day Average Volume | 1,395,668 | ||
1-Week Change | -1.49% | ||
1-Month Change | -7.83% | ||
1-Year Change | 39.67% | ||
3-Year Change | 9.95% | ||
5-Year Change | 113.69% | ||
Fundamentals | |||
Shares Outstanding | 148.8M | ||
Total Assets | $3.1B | ||
Market Cap | $8.3B | ||
Enterprise Value | $8.2B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$284.3M | ||
Free Cash Flow | -$236.8M | ||
EBIT | -$284.3M | ||
EBITDA | -$281.3M | ||
Net Working Capital | $1.3B | ||
EPS | -$1.97 | ||
Enterprise Value/EBITDA | -29 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -28 | ||
PEG | -2 | ||
Price/Free Cash Flow | -35 | ||
Price/Operating Cash Flow | -36 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue